A Flagship VentureLabs Company

Celexion LLC

One Kendall Square, Building 1400W
Suite B14302

Cambridge, MA  02139

Tel: 1-888-954-4722


Leadership:
Brian Baynes
CEO


Website:
www.celexionbio.com

Celexion LLC

Flagship Partners:  Harry Wilcox, Brian Baynes
Initial Investment: 
2009
Status: 
Private

Celexion is a bioengineering company that develops powerful platform technologies and products for partners in the pharmaceutical, industrial, agricultural, and consumer sectors. The company’s technologies include the SECANT platform for engineering high performance protein products, a library of human antibodies for therapeutic lead generation, enzymatic pathways for synthesis of a variety of high-value chemicals and materials from wastes and other inexpensive precursors, and a novel family of enzymes for manipulation of chromosome-sized DNA. 

Noubar Afeyan, Harry Wilcox and Brian Baynes are on the Board of Directors.